GENPACT (G)
NYSE Market Closed
Genpact Limited is a global professional services and technology company that helps large organisations redesign operations, apply data more effectively, and automate complex workflows. The company originated as a business process unit within General Electric before becoming an independent provider of outsourced operations, analytics, and digital transformation services. It serves clients across sectors where process knowledge, regulatory awareness, and scale are important, including banking, insurance, healthcare, consumer goods, manufacturing, and technology.
Genpact’s work spans digital operations, decision support, data engineering, application services, and consulting. Its teams manage and improve functions such as finance and accounting, supply chain, procurement, customer experience, risk, compliance, and claims processing. The company increasingly positions artificial intelligence, generative AI, and agentic automation as core parts of its offering, using domain-specific models and workflow tools to help clients reduce manual work, improve accuracy, and make faster decisions.
The business reports through industry-focused segments, including High Tech and Manufacturing, Financial Services, and Consumer and Healthcare. High Tech and Manufacturing is the largest contributor to revenue, reflecting demand from companies with large data sets, complex supply chains, and recurring operational needs. Genpact has a significant delivery presence in India and other global service hubs, while its customer base is international and includes multinational enterprises.
For investors, Genpact is best understood as a business services company moving deeper into AI-enabled transformation rather than a pure software vendor. Its competitive strengths include long-running client relationships, process expertise, and the ability to combine offshore delivery scale with sector-specific technology implementation.
Last updated
- Market Cap
- 5.6B
- P/E
- 9.83
- P/FCF
- 8.37
- P/S
- 1.09
- Enterprise Value
- 6.56B
- Sector
- Industrials
- Industry
- Management Consulting Services
- Address
- CANON'S COURT, HAMILTON, D0, HM 12
North America Business Process Outsourcing Market Forecast and Company Analysis Report 2025-2033 Featuring Accenture, Triniter, IBM, Cognizant, Concentrix, Wipro, Genpact, and Amdocs
Regulatory Affairs Outsourcing Market Analysis Report 2025: Globalization of Biopharmaceutical and Medical Device Companies Bolster Growth - Trends, Opportunities, and Forecasts 2020-2030
Industrial Services Market to Reach USD 65.76 Billion by 2032| SNS Insider
Europe Pharmacovigilance and Drug Safety Software Market Forecast, Regional Share and Growth Opportunity Analysis to 2031
Pharmaceutical Regulatory Affairs Research Report 2025-2030: Entry of Companies into the Global Market Fueling Growth
Why Genpact (G) is a Top Value Stock for the Long-Term
Reasons to Retain Genpact (G) Stock in Your Portfolio Now
Genpact (G) is a Top-Ranked Momentum Stock: Should You Buy?
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Here's Why Genpact (G) is a Strong Value Stock
Genpact (G) Shares Gain 7.6% Since Q1 Earnings Beat Estimates
Company News For May 13, 2024
Wall Street Breakfast: The Week Ahead
Genpact (G) Earnings Expected to Grow: Should You Buy?
ExlService Holdings (EXLS) Beats Q1 Earnings and Revenue Estimates
Barrett Business Services (BBSI) Reports Q1 Loss, Tops Revenue Estimates
Genpact (G) Gains From AI Product Portfolio Amid Low Liquidity
Stock Market News for Feb 12, 2024
Genpact's (G) Q4 Earnings Surpass Estimates, Increase Y/Y
Genpact (G) Surpasses Q4 Earnings and Revenue Estimates
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 5.6B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 6.56B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 9.83
- P/B
P/B ratio compares a company's share price to its book value per share.
- 2.26
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 1.09
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 7.54
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 1.27
- EPS
- 3.36
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 2.14%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 8.37
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 7.48
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 668.73M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 23.01%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 10.14%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.62
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 1.69
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 1.69
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.41
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 3.25M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 33.04
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 1.3B | 1.32B | 1.29B | 1.25B | 1.21B |
| Gross profit | 471.67M | 482.29M | 469.66M | 450.07M | 428.99M |
| Operating income | 198.58M | 197.79M | 199.27M | 179.36M | 183.7M |
| EBITDA | 219.43M | 223.83M | 225.47M | 200.87M | 204.91M |
| Net income | 147.99M | 143.09M | 145.83M | 132.72M | 130.85M |
| Basic EPS | 0.87 | 0.83 | 0.84 | 0.76 | 0.75 |
| Diluted EPS | 0.86 | 0.82 | 0.83 | 0.75 | 0.73 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 5.62B | 5.84B | 5.36B | 5.31B | 4.89B |
| Total liabilities | 3.14B | 3.29B | 2.82B | 2.72B | 2.44B |
| Total equity | 2.48B | 2.55B | 2.54B | 2.59B | 2.45B |
| Cash & equivalents | 578.08M | 853.84M | 740.76M | 663.26M | 561.62M |
| Current assets | 2.41B | 2.66B | 2.21B | 2.14B | 1.94B |
| Current liabilities | 1.43B | 1.6B | 1.46B | 1.39B | 791.74M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -23.54M | 286.7M | 308.36M | 177.37M | 40.44M |
| Investing cash flow | -31.45M | -371.86M | -19.22M | -105.2M | 779K |
| Financing cash flow | -204.33M | 208.82M | -208.96M | 18.87M | -125.54M |
| Change in cash | -259.32M | 123.65M | 80.19M | 91.04M | -84.33M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | SCHEDULE 13G — Genpact LTD | View Filing | |
| edgar index | 10-Q — Genpact LTD | View Filing | |
| edgar index | 8-K — Genpact LTD | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Genpact LTD | View Filing | |
| edgar index | SCHEDULE 13G — Genpact LTD | View Filing | |
| edgar index | SCHEDULE 13G — Genpact LTD | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| form 4 | Form 4 — Morken CeCelia | View Filing | |
| form 4 | Form 4 — Madden James C. | View Filing | |
| form 4 | Form 4 — Gangestad Nicholas C | View Filing | |
| form 4 | Form 4 — Conigliaro Laura | View Filing | |
| form 4 | Form 4 — Hinshaw John M | View Filing | |
| form 4 | Form 4 — Verdi Mark A | View Filing | |
| form 4 | Form 4 — Lindstrom Carol | View Filing | |
| form 4 | Form 4 — STEVENS BRIAN MARK | View Filing | |
| form 4 | Form 4 — Subaiya Thimaya K. | View Filing | |
| edgar index | SCHEDULE 13G/A — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | DEF 14A — Genpact LTD | View Filing | |
| edgar index | DEFA14A — Genpact LTD | View Filing | |
| edgar index | ARS — Genpact LTD | View Filing | |
| form 4 | Form 4 — Mehta Piyush | View Filing | |
| form 4 | Form 4 — Weiner Michael Hal | View Filing | |
| form 4 | Form 4 — Kalra Balkrishan | View Filing | |
| form 4 | Form 4 — Nanduru Anil | View Filing | |
| form 4 | Form 4 — Vashisht Riju | View Filing | |
| form 4 | Form 4 — Dewan Sameer | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 144 — Genpact LTD | View Filing | |
| form 4 | Form 4 — Kalra Balkrishan | View Filing | |
| form 4 | Form 4 — Kalra Balkrishan | View Filing | |
| form 4 | Form 4 — Kalra Balkrishan | View Filing | |
| form 4 | Form 4 — Mehta Piyush | View Filing | |
| form 4 | Form 4 — Weiner Michael Hal | View Filing | |
| form 4 | Form 4 — Kalra Balkrishan | View Filing | |
| form 4 | Form 4 — Nanduru Anil | View Filing | |
| form 4 | Form 4 — Vashisht Riju | View Filing | |
| form 4 | Form 4 — Dewan Sameer | View Filing | |
| edgar index | 10-K — Genpact LTD | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 8-K — Genpact LTD | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| edgar index | 4 — Genpact LTD | View Filing | |
| form 4 | Form 4 — Mehta Piyush | View Filing | |
| form 4 | Form 4 — Weiner Michael Hal | View Filing | |
| form 4 | Form 4 — Radesca Anthony J. | View Filing |